Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections.
about
Current and emerging azole antifungal agentsThe effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV-1-infected individualsLimited-sampling strategy models for itraconazole and hydroxy-itraconazole based on data from a bioequivalence studyMetabolism-based drug interactions involving oral azole antifungals in humans.The use of fluconazole and itraconazole in the treatment of Candida albicans infections: a review.Review of antifungal therapy and the severity index for assessing onychomycosis: part I.Discovery of itraconazole with broad-spectrum in vitro antienterovirus activity that targets nonstructural protein 3A.Stereospecific metabolism of itraconazole by CYP3A4: dioxolane ring scission of azole antifungalsItraconazole (Sporanox) in superficial and systemic fungal infections.Current use of anti-infectives in dermatology.Contribution of itraconazole metabolites to inhibition of CYP3A4 in vivo.A randomized comparative study to determine the effect of omeprazole on the peak serum concentration of itraconazole oral solution.Soluble itraconazole in tablet form using disordered drug delivery approach: critical scale-up considerations and bio-equivalence studies.In Vitro Antifungal Activities against Moulds Isolated from Dermatological Specimens.Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.Itraconazole inhibits TNF-α-induced CXCL10 expression in oral fibroblasts.Factors influencing cure rates of non-dermatophyte mold and Candida onychomycosis: analysis of outcomes in 81 patients who completed treatment.Pharmacokinetics of intravenous itraconazole in stable hemodialysis patients.Biomonitoring of the Genotoxic and Hepatotoxic Effects and Oxidative Stress Potentials of Itraconazole in Pregnant Rats.Current issues in onychomycosis.Isocratic high-performance liquid chromatographic method with ultraviolet detection for simultaneous determination of levels of voriconazole and itraconazole and its hydroxy metabolite in human serum.Itraconazole- and fluconazole-induced toxicity in rat hepatocytes: a comparative in vitro study.Hepatotoxicity induced by antifungal drugs itraconazole and fluconazole in rats: a comparative in vivo study.Research of Mrr1, Cap1 and MDR1 in Candida albicans resistant to azole medications.Prediction of area under the curve for a p-glycoprotein, a CYP3A4 and a CYP2C9 substrate using a single time point strategy: assessment using fexofenadine, itraconazole and losartan and metabolites.Pharmacokinetics and bioavailability of itraconazole oral solution in cats.Safety and efficacy of single-dose fluconazole compared with a 7-day regimen of itraconazole in the treatment of AIDS-related oropharyngeal candidiasis.
P2860
Q24550733-7367B435-BB01-41AF-A20A-D23FEAFBD4A5Q28367578-11B4A432-F260-4EEB-BD23-E67FB8878F5FQ31943628-ADF81716-0D55-4DFA-8A35-7E276311EE65Q33719828-506BE954-314D-485F-9D31-C42BDFFC2D49Q33788619-21F5AE9F-294D-4203-A846-1FC03A5FF921Q34779001-27358256-D254-46D1-AB87-A45AD44B0B6EQ35386030-44356FF7-AEEB-4964-A41A-7331660DC0C9Q35776638-FC80DCE1-0603-49F1-98EE-911FA4D170EAQ35917270-520B7A5D-1A17-429B-B92A-88BD91BC3910Q36233506-4745AB6F-92BD-4EE0-916B-3729B063B725Q36369136-A4C0AAD6-CEEB-4459-9FF3-0C84881F5A20Q36394086-E9696BF9-EE46-40AB-87D4-374755F16F92Q36636520-5C77DAEE-6296-43BB-900B-BA99044B0D0EQ37069725-0D168902-F770-4EF7-B64E-CEFA79011FD4Q38681635-A0D01AE5-346F-4114-B899-7FFA8C3C41ADQ39027402-1E7EFE47-8233-4D8C-931E-A0D28F8D47BBQ40464021-BA2E6033-C76F-48B7-8EAE-44184BBAC50AQ41269627-EEA2878E-796C-415E-B6D6-E208CD59742CQ41277870-BBF29E29-77AD-4CB7-BE5E-E306B96FFA10Q41718745-59DB55C0-482B-474A-9948-7F0F5BECB72FQ41936899-84BF5226-77B6-4A90-A772-78D35658F8E8Q44015814-63267059-0C4E-483F-9926-5A33DFB43EA5Q45206815-ACCFBE3A-7596-43E8-9CD2-A43A35D40B7FQ50054211-CC44CC62-A5A9-4CB3-A0C9-B5338F5093F3Q50924422-9ADFC833-3ACD-4422-AF8A-02FA99B4C434Q53525661-9A5E5DFD-C208-42B6-83E1-A4B3D9156833Q53947165-DBA7AE57-C556-46F8-9B0E-637E89899368
P2860
Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Itraconazole. A reappraisal of ...... superficial fungal infections.
@en
type
label
Itraconazole. A reappraisal of ...... superficial fungal infections.
@en
prefLabel
Itraconazole. A reappraisal of ...... superficial fungal infections.
@en
P2093
P1433
P1476
Itraconazole. A reappraisal of ...... superficial fungal infections.
@en
P2093
P304
P356
10.2165/00003495-199651040-00006
P577
1996-04-01T00:00:00Z
P5875
P6179
1047787407